These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7731691)

  • 21. NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells.
    Marte BM; Graus-Porta D; Jeschke M; Fabbro D; Hynes NE; Taverna D
    Oncogene; 1995 Jan; 10(1):167-75. PubMed ID: 7824269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
    Pinkas-Kramarski R; Soussan L; Waterman H; Levkowitz G; Alroy I; Klapper L; Lavi S; Seger R; Ratzkin BJ; Sela M; Yarden Y
    EMBO J; 1996 May; 15(10):2452-67. PubMed ID: 8665853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cyclooxygenase-2 pathway by HER2 receptor.
    Vadlamudi R; Mandal M; Adam L; Steinbach G; Mendelsohn J; Kumar R
    Oncogene; 1999 Jan; 18(2):305-14. PubMed ID: 9927187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
    Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
    Chen X; Levkowitz G; Tzahar E; Karunagaran D; Lavi S; Ben-Baruch N; Leitner O; Ratzkin BJ; Bacus SS; Yarden Y
    J Biol Chem; 1996 Mar; 271(13):7620-9. PubMed ID: 8631797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.
    Uchida T; Wada K; Akamatsu T; Yonezawa M; Noguchi H; Mizoguchi A; Kasuga M; Sakamoto C
    Biochem Biophys Res Commun; 1999 Dec; 266(2):593-602. PubMed ID: 10600548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional aspects of the multiplicity of Neu differentiation factors.
    Wen D; Suggs SV; Karunagaran D; Liu N; Cupples RL; Luo Y; Janssen AM; Ben-Baruch N; Trollinger DB; Jacobsen VL
    Mol Cell Biol; 1994 Mar; 14(3):1909-19. PubMed ID: 7509448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells.
    Daly JM; Jannot CB; Beerli RR; Graus-Porta D; Maurer FG; Hynes NE
    Cancer Res; 1997 Sep; 57(17):3804-11. PubMed ID: 9288791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schwann cells express NDF and SMDF/n-ARIA mRNAs, secrete neuregulin, and show constitutive activation of erbB3 receptors: evidence for a neuregulin autocrine loop.
    Rosenbaum C; Karyala S; Marchionni MA; Kim HA; Krasnoselsky AL; Happel B; Isaacs I; Brackenbury R; Ratner N
    Exp Neurol; 1997 Dec; 148(2):604-15. PubMed ID: 9417836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin alpha in human normal bronchial epithelial and lung cancer cell lines.
    al Moustafa AE; Alaoui-Jamali M; Paterson J; O'Connor-McCourt M
    Anticancer Res; 1999; 19(1A):481-6. PubMed ID: 10226586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bivalence of EGF-like ligands drives the ErbB signaling network.
    Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
    EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation.
    De Potter IY; Poumay Y; Squillace KA; Pittelkow MR
    Exp Cell Res; 2001 Dec; 271(2):315-28. PubMed ID: 11716544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of heregulin-alpha as a motility factor and amphiregulin as a growth factor in wound healing.
    Schelfhout VR; Coene ED; Delaey B; Waeytens AA; De Rycke L; Deleu M; De Potter CR
    J Pathol; 2002 Dec; 198(4):523-33. PubMed ID: 12434423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.
    Lupu R; Cardillo M; Harris L; Hijazi M; Rosenberg K
    Semin Cancer Biol; 1995 Jun; 6(3):135-45. PubMed ID: 7495981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors.
    Klapper LN; Vaisman N; Hurwitz E; Pinkas-Kramarski R; Yarden Y; Sela M
    Oncogene; 1997 May; 14(17):2099-109. PubMed ID: 9160890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.
    Jeschke M; Wels W; Dengler W; Imber R; Stöcklin E; Groner B
    Int J Cancer; 1995 Mar; 60(5):730-9. PubMed ID: 7860149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Neu differentiation factor (NDF) domain essential for proliferation and alterations in morphology of colonic epithelial cells in vitro.
    Whoriskey JS; Pekar SK; Elliott GS; Hara S; Liu N; Lenz DM; Zamborelli T; Mayer JP; Tarpley JE; Lacey DL; Ratzkin B; Yoshinaga SK
    Growth Factors; 1998; 15(4):307-21. PubMed ID: 9714914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.